Cite
MLA Citation
P Tolomeo et al.. “Implications of the 2021 CKD-EPI cystatin C/creatinine eGFR equation for eligibility for therapy in HFrEF: insights from PARADIGM-HF.” European heart journal, vol. 43, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100168330255.0x000043